Although c‑MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER‑positive breast cancer
Rui Chen(First Affiliated Hospital of Chongqing Medical University), Shengchun Liu(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Cited by 24
Related Papers
Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor
|Oncology Reports|2019|223
CXCL1 stimulates migration and invasion in ER‑negative breast cancer cells via activation of the ERK/MMP2/9 signaling axis
|International Journal of Oncology|2019|76
HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance
|Oncology Reports|2021|30
GBP2 enhances paclitaxel sensitivity in triple‑negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mTOR pathway
|International Journal of Oncology|2024|20